SUMMARY A copy of the standardised classification (SC) proposed for assessing dysplasia in inflammatory bowel disease was circulated to six histopathologists who were asked to apply it to 40 slides from 34 patients with ulcerative colitis to test its reproducibility. The slides were relabelled and recirculated to the pathologists at least one month later. Each was asked to state whether or not key diagnostic features were present before giving a final dysplasia score for the second assessment. Only minor interobserver and intraobserver disagreements were recorded. Pathologists were most consistent at recognising back to back glands, villous mucosal architecture, hyperchromatic nuclei, stratification of nuclei, regenerative nuclei and loss of nuclear polarity. There was poor interobserver agreement in assessing dystrophic goblet cells and columnar mucous cells.
Carcinoma of the colon is a complication of ulcerative colitis. ' 2 The risk increases with the duration of the disease and is greater in those with extensive ulcerative colitis. 3 4 Retrospective analysis of resected colons from patients with ulcerative colitis and carcinoma show dysplasia in the adjacent or distant mucosa.4-6 Colons removed from patients for dysplasia often contain carcinomas.`-Colonoscopy and biopsy have therefore become essential to the surveillance of carcinoma in ulcerative colitis, but there remain problems with the identification and interpretation of dysplasia, 0 and studies of observer variation in the recognition of individual criteria are needed. " To overcome the problems of interpretation of dysplasia an international working party was organised to produce a standardised classification of dysplasia and define criteria for its assessment. ' 
This group
Accepted for publication 27 May 1987 jointly produced a proposed classification of dysplasia and assessed its validity in 60 biopsy specimens. Although the group comprised international experts who had previously discussed two slide sets, they found "moderate variability" in the assessment of dysplasia. This may have been due to their selection of a deliberately difficult set of examples for assessment. No attempt was made to assess observer variation of the individual criteria proposed for determination of the grade of dysplasia. If this standardised classification (SC) is to gain widespread acceptance then the assessment of its validity in the reporting of a representative district general hospital workload is required. Our study was designed to determine how accurately the SC could be applied by a heterogeneous group of histopathologists to a representative slide set. The study was also designed to determine the interobserver variation of the proposed criteria and how each pathologist weighed them in determining the grade of dysplasia. 1282
Reliable assessment of dysplasia in chronic inflammatory bowel disease Material and methods All the pathology reports on rectal and colonic biopsy specimens between 1980 and 1986 from patients with chronic inflammatory bowel disease were examined to identify those cases in which the presence of dysplasia had been mentioned. The slides from these 62 cases were examined by one observer who selected 40 slides. The 40 slides had been made of 40 rectal or colonic biopsy specimens from 34 patients (17 men and 17 women; mean age 48, range 23-86 years). Thirty patients did not have carcinoma (mean 12 years, range one to 30), four did have carcinoma (mean 16 years, range four to 26). The slides showed a spectrum of dysplastic changes from inactive colitis (negative for dysplasia) to high grade dysplasia according to the criteria of Riddell et al. 12 The notes and pathological reports on each of the 34 patients from which the slides were selected were reviewed. Eight slides were selected from four patients who subsequently had colectomies carried out for colonic carcinoma.
Six histopathologists-two with a specialised interest in gastroenterology, two with a specialised interest in dermatopathology, and two district general hospital pathologists-took part in the study. All except one had passed the final MRCPath examination, and experience varied between four and 20 years.
Each pathologist was given a copy of the SC proposed by Riddell et al12 at least two weeks before receiving the slides. They were instructed to read the SC paper and then grade each slide according to the proposed criteria on a numerical scale of 0-7 (table 1) (assessment 1). The slides were randomised by a third party, relabelled, and recirculated to each pathologist at least one month later. On the second assessment the pathologists were asked to state whether or not the SC features were present in the "most dysplastic" glands to any significant degree in every slide and then score each slide on the same 0-7 scale. Intraobserver variability was assessed by calculating the rank of correlation coefficients between the two assessments for each observer. Random effects analysis of variance'3 was used to measure the variability between assessors on each of the two assess- The importance of each feature in the assessment for each slide was determined by modelling the overall score on the presence or absence of each feature in a regression model. The model appropriate for this was the ordinal logistic model."4 This allows the (partial) correlation of each feature with the score to be measured; rankings of the importance of these features can then be based on the magnitude of the correlation.
Results

CASE REPORTS
Case I was a woman whose colitis had begun at 43 years of age; 14 years later she was referred to our hospital with a right iliac fossa mass, and radiological investigations showed a possible carcinoma. A rectal biopsy specimen showed chronic ulcerative colitis and moderate dysplasia (mean study score 5-1). The colectomy specimen showed Dukes' grade C adenocarcinoma; she died 14 months later with disseminated adenocarcinoma. Case 2 was a man whose colitis had begun at 55. His first colonic examination was carried out 14 years later following the onset of anaemia. Biopsy specimens showed chronic ulcerative colitis to the hepatic flexure and severe dysplasia (mean study score [6] [7] [8] . A colectomy was carried out and this showed Dukes' A adenocarcinoma. Case 3 was a woman whose colitis had begun at 27. She had intermittent colitis managed with salazopyrin, prednisolone enemas, and oral prednisolone. Early rectal and colonoscopic biopsy specimens showed ulcerative colitis with no or moderate dysplasia. Severe dysplasia (mean study score 6-3) was first reported 18 years after the onset of colitis. A colectomy carried out two years later (delayed due to patient resistance) showed Dukes' B adenocarcinoma. At the time of writing she was being treated for ovarian and liver metastases. Case 4 was a man whose colitis had begun at 50. A rectal biopsy performed one year after the onset of colitis showed moderate dysplasia (mean study score 1284 4 1); this was followed by multiple rectal and colonoscopic biopsies. The specimens showed moderate (mean study score 5 7), mild (mean study score 5-0), severe (mean study score 5 7) and severe (mean study score [5] [6] [7] [8] Dundas, Kay, Beck, Cotton, Coup, Slater, Underwood Table 4 shows that there were 150 readings of biopsy specimens with a mean score of 3 49 or less (negative or probably negative for dysplasia). Of these, on 112 occasions the biopsy specimens were correctly read as negative or probably negative for dysplasia. There were 32 readings assigning specimens to the unknown or probably positive category. There were six false readings of low grade dysplasia which clinically would result in a repeat biopsy. There were no false readings of high grade dysplasia which would result in inappropriate colectomy.
There were 30 readings of biopsy specimens as high grade dysplasia. On 21 occasions the biopsy specimens were correctly read. There were nine false negative readings, assigning specimens to the probably negative, indefinite or low grade dysplasia category; this would result clinically in a repeat biopsy. There were no false readings assigning biopsy specimens from the high grade dysplasia category into the negative group.
Reliable assessment of dysplasia in chronic inflammatory bowel disease We have shown that the SC proposed by Riddell et al can be reliably applied to colonoscopic biopsy specimens by a group of histopathologists of different special interest. There is still a minor degree of difference in opinion between experts and the nonexperts in our study. This may be improved by more precise definition of features such as "columnar mucous cells" and "dystrophic goblet cells"; alternatively, these features should not be included in the SC.
